nodes	percent_of_prediction	percent_of_DWPC	metapath
Propofol—CYP2E1—liver cancer	0.174	0.394	CbGaD
Propofol—CYP1A1—liver cancer	0.172	0.389	CbGaD
Propofol—ALB—liver cancer	0.0958	0.217	CbGaD
Propofol—UGT1A9—Sorafenib—liver cancer	0.0852	0.244	CbGbCtD
Propofol—UGT1A1—Sorafenib—liver cancer	0.0697	0.2	CbGbCtD
Propofol—CYP1B1—Doxorubicin—liver cancer	0.0489	0.14	CbGbCtD
Propofol—CYP2B6—Sorafenib—liver cancer	0.0269	0.0773	CbGbCtD
Propofol—CYP2C8—Sorafenib—liver cancer	0.0204	0.0585	CbGbCtD
Propofol—CYP2C19—Sorafenib—liver cancer	0.0171	0.0491	CbGbCtD
Propofol—CYP2B6—Doxorubicin—liver cancer	0.0163	0.0469	CbGbCtD
Propofol—CYP1A2—Sorafenib—liver cancer	0.0158	0.0453	CbGbCtD
Propofol—CYP2C9—Sorafenib—liver cancer	0.0142	0.0408	CbGbCtD
Propofol—CYP2D6—Sorafenib—liver cancer	0.013	0.0373	CbGbCtD
Propofol—CYP3A4—Sorafenib—liver cancer	0.00828	0.0237	CbGbCtD
Propofol—CYP2D6—Doxorubicin—liver cancer	0.0079	0.0226	CbGbCtD
Propofol—CYP3A4—Doxorubicin—liver cancer	0.00502	0.0144	CbGbCtD
Propofol—Fospropofol—ALPL—liver cancer	0.00502	0.878	CrCbGaD
Propofol—Electrocardiogram ST segment depression—Epirubicin—liver cancer	0.00147	0.0219	CcSEcCtD
Propofol—Electrocardiogram ST segment depression—Doxorubicin—liver cancer	0.00136	0.0202	CcSEcCtD
Propofol—Myocardial ischaemia—Sorafenib—liver cancer	0.00112	0.0167	CcSEcCtD
Propofol—Rhabdomyolysis—Sorafenib—liver cancer	0.00102	0.0152	CcSEcCtD
Propofol—Supraventricular extrasystoles—Epirubicin—liver cancer	0.000895	0.0133	CcSEcCtD
Propofol—Neuropathy—Sorafenib—liver cancer	0.000847	0.0126	CcSEcCtD
Propofol—Supraventricular extrasystoles—Doxorubicin—liver cancer	0.000828	0.0123	CcSEcCtD
Propofol—Fospropofol—ALB—liver cancer	0.000696	0.122	CrCbGaD
Propofol—Cardiac failure—Sorafenib—liver cancer	0.000671	0.00999	CcSEcCtD
Propofol—Muscle relaxant therapy—Epirubicin—liver cancer	0.00067	0.00997	CcSEcCtD
Propofol—Bundle branch block—Epirubicin—liver cancer	0.000661	0.00983	CcSEcCtD
Propofol—Pain in extremity—Sorafenib—liver cancer	0.000655	0.00975	CcSEcCtD
Propofol—Hypotonia—Epirubicin—liver cancer	0.000634	0.00944	CcSEcCtD
Propofol—Mood swings—Sorafenib—liver cancer	0.000621	0.00923	CcSEcCtD
Propofol—Muscle relaxant therapy—Doxorubicin—liver cancer	0.00062	0.00923	CcSEcCtD
Propofol—Bundle branch block—Doxorubicin—liver cancer	0.000611	0.0091	CcSEcCtD
Propofol—Dehydration—Sorafenib—liver cancer	0.000609	0.00907	CcSEcCtD
Propofol—Urine abnormality—Epirubicin—liver cancer	0.000602	0.00896	CcSEcCtD
Propofol—Hypotonia—Doxorubicin—liver cancer	0.000587	0.00873	CcSEcCtD
Propofol—Urine abnormality—Doxorubicin—liver cancer	0.000557	0.00829	CcSEcCtD
Propofol—Pancreatitis—Sorafenib—liver cancer	0.000555	0.00826	CcSEcCtD
Propofol—Hypomagnesaemia—Epirubicin—liver cancer	0.000525	0.00781	CcSEcCtD
Propofol—Acute coronary syndrome—Sorafenib—liver cancer	0.000498	0.00741	CcSEcCtD
Propofol—Renal failure—Sorafenib—liver cancer	0.000496	0.00738	CcSEcCtD
Propofol—Neuropathy peripheral—Sorafenib—liver cancer	0.000495	0.00736	CcSEcCtD
Propofol—Myocardial infarction—Sorafenib—liver cancer	0.000495	0.00736	CcSEcCtD
Propofol—Redness—Epirubicin—liver cancer	0.000494	0.00735	CcSEcCtD
Propofol—Hypomagnesaemia—Doxorubicin—liver cancer	0.000486	0.00723	CcSEcCtD
Propofol—Hyperventilation—Epirubicin—liver cancer	0.000485	0.00721	CcSEcCtD
Propofol—Thrombosis—Epirubicin—liver cancer	0.000471	0.00701	CcSEcCtD
Propofol—Ileus—Epirubicin—liver cancer	0.000471	0.00701	CcSEcCtD
Propofol—Nystagmus—Epirubicin—liver cancer	0.000467	0.00695	CcSEcCtD
Propofol—Hyperlipidaemia—Epirubicin—liver cancer	0.000463	0.00689	CcSEcCtD
Propofol—Redness—Doxorubicin—liver cancer	0.000457	0.0068	CcSEcCtD
Propofol—Haemoglobin—Sorafenib—liver cancer	0.000455	0.00678	CcSEcCtD
Propofol—Haemorrhage—Sorafenib—liver cancer	0.000453	0.00674	CcSEcCtD
Propofol—Hyperventilation—Doxorubicin—liver cancer	0.000448	0.00667	CcSEcCtD
Propofol—Ileus—Doxorubicin—liver cancer	0.000436	0.00649	CcSEcCtD
Propofol—Thrombosis—Doxorubicin—liver cancer	0.000436	0.00649	CcSEcCtD
Propofol—Nystagmus—Doxorubicin—liver cancer	0.000432	0.00643	CcSEcCtD
Propofol—Amblyopia—Epirubicin—liver cancer	0.000432	0.00643	CcSEcCtD
Propofol—Hyperlipidaemia—Doxorubicin—liver cancer	0.000428	0.00637	CcSEcCtD
Propofol—Tinnitus—Sorafenib—liver cancer	0.000422	0.00629	CcSEcCtD
Propofol—Flushing—Sorafenib—liver cancer	0.000421	0.00626	CcSEcCtD
Propofol—Stinging—Epirubicin—liver cancer	0.000412	0.00613	CcSEcCtD
Propofol—Injection site pain—Epirubicin—liver cancer	0.000408	0.00608	CcSEcCtD
Propofol—Arrhythmia—Sorafenib—liver cancer	0.000405	0.00602	CcSEcCtD
Propofol—Amblyopia—Doxorubicin—liver cancer	0.0004	0.00595	CcSEcCtD
Propofol—Erythema—Sorafenib—liver cancer	0.000394	0.00587	CcSEcCtD
Propofol—Delirium—Epirubicin—liver cancer	0.000388	0.00577	CcSEcCtD
Propofol—Dysgeusia—Sorafenib—liver cancer	0.000386	0.00575	CcSEcCtD
Propofol—Extravasation—Epirubicin—liver cancer	0.000382	0.00569	CcSEcCtD
Propofol—Stinging—Doxorubicin—liver cancer	0.000381	0.00567	CcSEcCtD
Propofol—Muscle spasms—Sorafenib—liver cancer	0.000379	0.00564	CcSEcCtD
Propofol—Injection site pain—Doxorubicin—liver cancer	0.000378	0.00562	CcSEcCtD
Propofol—Ventricular extrasystoles—Epirubicin—liver cancer	0.000369	0.00549	CcSEcCtD
Propofol—Thinking abnormal—Epirubicin—liver cancer	0.000364	0.00542	CcSEcCtD
Propofol—Oliguria—Epirubicin—liver cancer	0.000362	0.00539	CcSEcCtD
Propofol—Angioedema—Sorafenib—liver cancer	0.00036	0.00536	CcSEcCtD
Propofol—Delirium—Doxorubicin—liver cancer	0.000359	0.00534	CcSEcCtD
Propofol—Dyskinesia—Epirubicin—liver cancer	0.000355	0.00528	CcSEcCtD
Propofol—Syncope—Sorafenib—liver cancer	0.000354	0.00526	CcSEcCtD
Propofol—Extravasation—Doxorubicin—liver cancer	0.000354	0.00526	CcSEcCtD
Propofol—Creatinine increased—Epirubicin—liver cancer	0.00035	0.00521	CcSEcCtD
Propofol—Loss of consciousness—Sorafenib—liver cancer	0.000347	0.00516	CcSEcCtD
Propofol—Cough—Sorafenib—liver cancer	0.000344	0.00512	CcSEcCtD
Propofol—Atrioventricular block—Epirubicin—liver cancer	0.000344	0.00512	CcSEcCtD
Propofol—Ventricular extrasystoles—Doxorubicin—liver cancer	0.000342	0.00508	CcSEcCtD
Propofol—Hypertension—Sorafenib—liver cancer	0.000341	0.00507	CcSEcCtD
Propofol—Thinking abnormal—Doxorubicin—liver cancer	0.000337	0.00502	CcSEcCtD
Propofol—Myalgia—Sorafenib—liver cancer	0.000336	0.005	CcSEcCtD
Propofol—Oliguria—Doxorubicin—liver cancer	0.000335	0.00498	CcSEcCtD
Propofol—Ventricular tachycardia—Epirubicin—liver cancer	0.000334	0.00496	CcSEcCtD
Propofol—Hiccups—Epirubicin—liver cancer	0.000334	0.00496	CcSEcCtD
Propofol—Abnormal dreams—Epirubicin—liver cancer	0.00033	0.0049	CcSEcCtD
Propofol—Dry mouth—Sorafenib—liver cancer	0.000328	0.00489	CcSEcCtD
Propofol—Dyskinesia—Doxorubicin—liver cancer	0.000328	0.00489	CcSEcCtD
Propofol—Hyperkalaemia—Epirubicin—liver cancer	0.000328	0.00488	CcSEcCtD
Propofol—Creatinine increased—Doxorubicin—liver cancer	0.000324	0.00482	CcSEcCtD
Propofol—Salivary hypersecretion—Epirubicin—liver cancer	0.000324	0.00482	CcSEcCtD
Propofol—Anaphylactic shock—Sorafenib—liver cancer	0.000322	0.00479	CcSEcCtD
Propofol—Atrioventricular block—Doxorubicin—liver cancer	0.000318	0.00473	CcSEcCtD
Propofol—Shock—Sorafenib—liver cancer	0.000317	0.00471	CcSEcCtD
Propofol—Blood urea increased—Epirubicin—liver cancer	0.000315	0.00469	CcSEcCtD
Propofol—Neuropathy—Epirubicin—liver cancer	0.000313	0.00466	CcSEcCtD
Propofol—Hiccups—Doxorubicin—liver cancer	0.000309	0.00459	CcSEcCtD
Propofol—Ventricular tachycardia—Doxorubicin—liver cancer	0.000309	0.00459	CcSEcCtD
Propofol—Abnormal dreams—Doxorubicin—liver cancer	0.000305	0.00454	CcSEcCtD
Propofol—Hyperkalaemia—Doxorubicin—liver cancer	0.000303	0.00451	CcSEcCtD
Propofol—Salivary hypersecretion—Doxorubicin—liver cancer	0.0003	0.00446	CcSEcCtD
Propofol—Pulmonary oedema—Epirubicin—liver cancer	0.000297	0.00442	CcSEcCtD
Propofol—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000293	0.00436	CcSEcCtD
Propofol—Hypertonia—Epirubicin—liver cancer	0.000292	0.00435	CcSEcCtD
Propofol—Blood urea increased—Doxorubicin—liver cancer	0.000291	0.00434	CcSEcCtD
Propofol—Abnormal vision—Epirubicin—liver cancer	0.000291	0.00433	CcSEcCtD
Propofol—Neuropathy—Doxorubicin—liver cancer	0.00029	0.00431	CcSEcCtD
Propofol—Sepsis—Epirubicin—liver cancer	0.000289	0.00431	CcSEcCtD
Propofol—Mental disability—Epirubicin—liver cancer	0.000289	0.00431	CcSEcCtD
Propofol—Dyspnoea—Sorafenib—liver cancer	0.000287	0.00427	CcSEcCtD
Propofol—Phlebitis—Epirubicin—liver cancer	0.000281	0.00418	CcSEcCtD
Propofol—Fatigue—Sorafenib—liver cancer	0.000278	0.00413	CcSEcCtD
Propofol—Pain—Sorafenib—liver cancer	0.000275	0.0041	CcSEcCtD
Propofol—Pulmonary oedema—Doxorubicin—liver cancer	0.000275	0.00409	CcSEcCtD
Propofol—Hypertonia—Doxorubicin—liver cancer	0.00027	0.00403	CcSEcCtD
Propofol—Abnormal vision—Doxorubicin—liver cancer	0.000269	0.004	CcSEcCtD
Propofol—Eye pain—Epirubicin—liver cancer	0.000268	0.00399	CcSEcCtD
Propofol—Mental disability—Doxorubicin—liver cancer	0.000268	0.00398	CcSEcCtD
Propofol—Sepsis—Doxorubicin—liver cancer	0.000268	0.00398	CcSEcCtD
Propofol—Phlebitis—Doxorubicin—liver cancer	0.00026	0.00387	CcSEcCtD
Propofol—Urticaria—Sorafenib—liver cancer	0.000256	0.00381	CcSEcCtD
Propofol—Body temperature increased—Sorafenib—liver cancer	0.000254	0.00379	CcSEcCtD
Propofol—Abdominal pain—Sorafenib—liver cancer	0.000254	0.00379	CcSEcCtD
Propofol—Anaphylactoid reaction—Epirubicin—liver cancer	0.00025	0.00372	CcSEcCtD
Propofol—Eye pain—Doxorubicin—liver cancer	0.000248	0.00369	CcSEcCtD
Propofol—Cardiac failure—Epirubicin—liver cancer	0.000248	0.00369	CcSEcCtD
Propofol—Diplopia—Epirubicin—liver cancer	0.000242	0.0036	CcSEcCtD
Propofol—Pain in extremity—Epirubicin—liver cancer	0.000242	0.0036	CcSEcCtD
Propofol—Affect lability—Epirubicin—liver cancer	0.000238	0.00355	CcSEcCtD
Propofol—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000231	0.00344	CcSEcCtD
Propofol—Asthenia—Sorafenib—liver cancer	0.000231	0.00344	CcSEcCtD
Propofol—Cardiac arrest—Epirubicin—liver cancer	0.00023	0.00343	CcSEcCtD
Propofol—Cardiac failure—Doxorubicin—liver cancer	0.00023	0.00342	CcSEcCtD
Propofol—Mood swings—Epirubicin—liver cancer	0.000229	0.00341	CcSEcCtD
Propofol—Pruritus—Sorafenib—liver cancer	0.000228	0.00339	CcSEcCtD
Propofol—Blood creatinine increased—Epirubicin—liver cancer	0.000227	0.00337	CcSEcCtD
Propofol—Dehydration—Epirubicin—liver cancer	0.000225	0.00335	CcSEcCtD
Propofol—Pain in extremity—Doxorubicin—liver cancer	0.000224	0.00333	CcSEcCtD
Propofol—Diplopia—Doxorubicin—liver cancer	0.000224	0.00333	CcSEcCtD
Propofol—Affect lability—Doxorubicin—liver cancer	0.00022	0.00328	CcSEcCtD
Propofol—Diarrhoea—Sorafenib—liver cancer	0.00022	0.00328	CcSEcCtD
Propofol—Cardiac arrest—Doxorubicin—liver cancer	0.000213	0.00317	CcSEcCtD
Propofol—Dizziness—Sorafenib—liver cancer	0.000213	0.00317	CcSEcCtD
Propofol—Mood swings—Doxorubicin—liver cancer	0.000212	0.00316	CcSEcCtD
Propofol—Blood creatinine increased—Doxorubicin—liver cancer	0.00021	0.00312	CcSEcCtD
Propofol—Dehydration—Doxorubicin—liver cancer	0.000208	0.0031	CcSEcCtD
Propofol—Pancreatitis—Epirubicin—liver cancer	0.000205	0.00305	CcSEcCtD
Propofol—Vomiting—Sorafenib—liver cancer	0.000205	0.00305	CcSEcCtD
Propofol—Rash—Sorafenib—liver cancer	0.000203	0.00302	CcSEcCtD
Propofol—Dermatitis—Sorafenib—liver cancer	0.000203	0.00302	CcSEcCtD
Propofol—Headache—Sorafenib—liver cancer	0.000202	0.003	CcSEcCtD
Propofol—Nausea—Sorafenib—liver cancer	0.000191	0.00285	CcSEcCtD
Propofol—Pancreatitis—Doxorubicin—liver cancer	0.00019	0.00282	CcSEcCtD
Propofol—Hyperglycaemia—Epirubicin—liver cancer	0.000189	0.00281	CcSEcCtD
Propofol—Renal failure—Epirubicin—liver cancer	0.000183	0.00273	CcSEcCtD
Propofol—Neuropathy peripheral—Epirubicin—liver cancer	0.000183	0.00272	CcSEcCtD
Propofol—Hyperglycaemia—Doxorubicin—liver cancer	0.000175	0.0026	CcSEcCtD
Propofol—Bradycardia—Epirubicin—liver cancer	0.00017	0.00254	CcSEcCtD
Propofol—Renal failure—Doxorubicin—liver cancer	0.00017	0.00253	CcSEcCtD
Propofol—Neuropathy peripheral—Doxorubicin—liver cancer	0.000169	0.00252	CcSEcCtD
Propofol—Haemoglobin—Epirubicin—liver cancer	0.000168	0.0025	CcSEcCtD
Propofol—Haemorrhage—Epirubicin—liver cancer	0.000167	0.00249	CcSEcCtD
Propofol—Pharyngitis—Epirubicin—liver cancer	0.000166	0.00247	CcSEcCtD
Propofol—Visual impairment—Epirubicin—liver cancer	0.000161	0.0024	CcSEcCtD
Propofol—Bradycardia—Doxorubicin—liver cancer	0.000158	0.00235	CcSEcCtD
Propofol—Tinnitus—Epirubicin—liver cancer	0.000156	0.00232	CcSEcCtD
Propofol—Haemoglobin—Doxorubicin—liver cancer	0.000156	0.00232	CcSEcCtD
Propofol—Flushing—Epirubicin—liver cancer	0.000155	0.00231	CcSEcCtD
Propofol—Haemorrhage—Doxorubicin—liver cancer	0.000155	0.00231	CcSEcCtD
Propofol—Pharyngitis—Doxorubicin—liver cancer	0.000154	0.00229	CcSEcCtD
Propofol—Chills—Epirubicin—liver cancer	0.00015	0.00224	CcSEcCtD
Propofol—Arrhythmia—Epirubicin—liver cancer	0.00015	0.00223	CcSEcCtD
Propofol—Visual impairment—Doxorubicin—liver cancer	0.000149	0.00222	CcSEcCtD
Propofol—Erythema—Epirubicin—liver cancer	0.000146	0.00217	CcSEcCtD
Propofol—Tinnitus—Doxorubicin—liver cancer	0.000144	0.00215	CcSEcCtD
Propofol—Flushing—Doxorubicin—liver cancer	0.000144	0.00214	CcSEcCtD
Propofol—Dysgeusia—Epirubicin—liver cancer	0.000143	0.00212	CcSEcCtD
Propofol—Muscle spasms—Epirubicin—liver cancer	0.00014	0.00209	CcSEcCtD
Propofol—Chills—Doxorubicin—liver cancer	0.000139	0.00207	CcSEcCtD
Propofol—Arrhythmia—Doxorubicin—liver cancer	0.000138	0.00206	CcSEcCtD
Propofol—Erythema—Doxorubicin—liver cancer	0.000135	0.00201	CcSEcCtD
Propofol—Agitation—Epirubicin—liver cancer	0.000134	0.00199	CcSEcCtD
Propofol—Dysgeusia—Doxorubicin—liver cancer	0.000132	0.00197	CcSEcCtD
Propofol—Syncope—Epirubicin—liver cancer	0.000131	0.00195	CcSEcCtD
Propofol—Muscle spasms—Doxorubicin—liver cancer	0.00013	0.00193	CcSEcCtD
Propofol—Loss of consciousness—Epirubicin—liver cancer	0.000128	0.00191	CcSEcCtD
Propofol—Cough—Epirubicin—liver cancer	0.000127	0.00189	CcSEcCtD
Propofol—Convulsion—Epirubicin—liver cancer	0.000126	0.00188	CcSEcCtD
Propofol—Hypertension—Epirubicin—liver cancer	0.000126	0.00187	CcSEcCtD
Propofol—Chest pain—Epirubicin—liver cancer	0.000124	0.00185	CcSEcCtD
Propofol—Myalgia—Epirubicin—liver cancer	0.000124	0.00185	CcSEcCtD
Propofol—Agitation—Doxorubicin—liver cancer	0.000124	0.00184	CcSEcCtD
Propofol—Anxiety—Epirubicin—liver cancer	0.000124	0.00184	CcSEcCtD
Propofol—Dry mouth—Epirubicin—liver cancer	0.000121	0.00181	CcSEcCtD
Propofol—Syncope—Doxorubicin—liver cancer	0.000121	0.0018	CcSEcCtD
Propofol—Confusional state—Epirubicin—liver cancer	0.00012	0.00179	CcSEcCtD
Propofol—Anaphylactic shock—Epirubicin—liver cancer	0.000119	0.00177	CcSEcCtD
Propofol—Oedema—Epirubicin—liver cancer	0.000119	0.00177	CcSEcCtD
Propofol—Loss of consciousness—Doxorubicin—liver cancer	0.000119	0.00176	CcSEcCtD
Propofol—Cough—Doxorubicin—liver cancer	0.000118	0.00175	CcSEcCtD
Propofol—Shock—Epirubicin—liver cancer	0.000117	0.00174	CcSEcCtD
Propofol—Convulsion—Doxorubicin—liver cancer	0.000117	0.00174	CcSEcCtD
Propofol—Hypertension—Doxorubicin—liver cancer	0.000116	0.00173	CcSEcCtD
Propofol—Tachycardia—Epirubicin—liver cancer	0.000116	0.00173	CcSEcCtD
Propofol—Hyperhidrosis—Epirubicin—liver cancer	0.000115	0.00171	CcSEcCtD
Propofol—Chest pain—Doxorubicin—liver cancer	0.000115	0.00171	CcSEcCtD
Propofol—Myalgia—Doxorubicin—liver cancer	0.000115	0.00171	CcSEcCtD
Propofol—Anxiety—Doxorubicin—liver cancer	0.000114	0.0017	CcSEcCtD
Propofol—Dry mouth—Doxorubicin—liver cancer	0.000112	0.00167	CcSEcCtD
Propofol—Hypotension—Epirubicin—liver cancer	0.000111	0.00165	CcSEcCtD
Propofol—Confusional state—Doxorubicin—liver cancer	0.000111	0.00165	CcSEcCtD
Propofol—Anaphylactic shock—Doxorubicin—liver cancer	0.00011	0.00164	CcSEcCtD
Propofol—Oedema—Doxorubicin—liver cancer	0.00011	0.00164	CcSEcCtD
Propofol—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000108	0.00161	CcSEcCtD
Propofol—Shock—Doxorubicin—liver cancer	0.000108	0.00161	CcSEcCtD
Propofol—Insomnia—Epirubicin—liver cancer	0.000108	0.0016	CcSEcCtD
Propofol—Tachycardia—Doxorubicin—liver cancer	0.000107	0.0016	CcSEcCtD
Propofol—Paraesthesia—Epirubicin—liver cancer	0.000107	0.00159	CcSEcCtD
Propofol—Hyperhidrosis—Doxorubicin—liver cancer	0.000106	0.00158	CcSEcCtD
Propofol—Dyspnoea—Epirubicin—liver cancer	0.000106	0.00158	CcSEcCtD
Propofol—Somnolence—Epirubicin—liver cancer	0.000106	0.00157	CcSEcCtD
Propofol—Hypotension—Doxorubicin—liver cancer	0.000103	0.00153	CcSEcCtD
Propofol—Fatigue—Epirubicin—liver cancer	0.000103	0.00153	CcSEcCtD
Propofol—Pain—Epirubicin—liver cancer	0.000102	0.00151	CcSEcCtD
Propofol—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.0001	0.00149	CcSEcCtD
Propofol—Insomnia—Doxorubicin—liver cancer	9.96e-05	0.00148	CcSEcCtD
Propofol—Paraesthesia—Doxorubicin—liver cancer	9.89e-05	0.00147	CcSEcCtD
Propofol—Dyspnoea—Doxorubicin—liver cancer	9.81e-05	0.00146	CcSEcCtD
Propofol—Feeling abnormal—Epirubicin—liver cancer	9.8e-05	0.00146	CcSEcCtD
Propofol—Somnolence—Doxorubicin—liver cancer	9.79e-05	0.00146	CcSEcCtD
Propofol—Fatigue—Doxorubicin—liver cancer	9.49e-05	0.00141	CcSEcCtD
Propofol—Urticaria—Epirubicin—liver cancer	9.45e-05	0.00141	CcSEcCtD
Propofol—Pain—Doxorubicin—liver cancer	9.41e-05	0.0014	CcSEcCtD
Propofol—Abdominal pain—Epirubicin—liver cancer	9.41e-05	0.0014	CcSEcCtD
Propofol—Body temperature increased—Epirubicin—liver cancer	9.41e-05	0.0014	CcSEcCtD
Propofol—Feeling abnormal—Doxorubicin—liver cancer	9.07e-05	0.00135	CcSEcCtD
Propofol—Urticaria—Doxorubicin—liver cancer	8.75e-05	0.0013	CcSEcCtD
Propofol—Body temperature increased—Doxorubicin—liver cancer	8.7e-05	0.0013	CcSEcCtD
Propofol—Abdominal pain—Doxorubicin—liver cancer	8.7e-05	0.0013	CcSEcCtD
Propofol—Asthenia—Epirubicin—liver cancer	8.54e-05	0.00127	CcSEcCtD
Propofol—Pruritus—Epirubicin—liver cancer	8.42e-05	0.00125	CcSEcCtD
Propofol—Diarrhoea—Epirubicin—liver cancer	8.14e-05	0.00121	CcSEcCtD
Propofol—Asthenia—Doxorubicin—liver cancer	7.9e-05	0.00118	CcSEcCtD
Propofol—Dizziness—Epirubicin—liver cancer	7.87e-05	0.00117	CcSEcCtD
Propofol—Pruritus—Doxorubicin—liver cancer	7.79e-05	0.00116	CcSEcCtD
Propofol—Vomiting—Epirubicin—liver cancer	7.56e-05	0.00113	CcSEcCtD
Propofol—Diarrhoea—Doxorubicin—liver cancer	7.53e-05	0.00112	CcSEcCtD
Propofol—Rash—Epirubicin—liver cancer	7.5e-05	0.00112	CcSEcCtD
Propofol—Dermatitis—Epirubicin—liver cancer	7.49e-05	0.00112	CcSEcCtD
Propofol—Headache—Epirubicin—liver cancer	7.45e-05	0.00111	CcSEcCtD
Propofol—Dizziness—Doxorubicin—liver cancer	7.28e-05	0.00108	CcSEcCtD
Propofol—Nausea—Epirubicin—liver cancer	7.07e-05	0.00105	CcSEcCtD
Propofol—Vomiting—Doxorubicin—liver cancer	7e-05	0.00104	CcSEcCtD
Propofol—Rash—Doxorubicin—liver cancer	6.94e-05	0.00103	CcSEcCtD
Propofol—Dermatitis—Doxorubicin—liver cancer	6.93e-05	0.00103	CcSEcCtD
Propofol—Headache—Doxorubicin—liver cancer	6.9e-05	0.00103	CcSEcCtD
Propofol—Nausea—Doxorubicin—liver cancer	6.54e-05	0.000973	CcSEcCtD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	5.09e-06	3.73e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—ALDOB—liver cancer	5.07e-06	3.72e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CPT1B—liver cancer	5.06e-06	3.72e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GLUL—liver cancer	5.06e-06	3.72e-05	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	5.06e-06	3.72e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CYCS—liver cancer	5.06e-06	3.71e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—HPGDS—liver cancer	4.99e-06	3.67e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—GOT1—liver cancer	4.96e-06	3.64e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—GGT1—liver cancer	4.96e-06	3.64e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CYP2E1—liver cancer	4.96e-06	3.64e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—HPGDS—liver cancer	4.95e-06	3.63e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CG—liver cancer	4.94e-06	3.63e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—CYP2E1—liver cancer	4.93e-06	3.62e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.92e-06	3.61e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.91e-06	3.61e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—NR1H4—liver cancer	4.88e-06	3.59e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—MTHFR—liver cancer	4.86e-06	3.57e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.85e-06	3.56e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CRABP1—liver cancer	4.84e-06	3.55e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PSMA4—liver cancer	4.84e-06	3.55e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PSMD10—liver cancer	4.84e-06	3.55e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—GSTP1—liver cancer	4.83e-06	3.55e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—IL2—liver cancer	4.81e-06	3.53e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GSTA3—liver cancer	4.8e-06	3.53e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.8e-06	3.52e-05	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.77e-06	3.5e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PPARG—liver cancer	4.77e-06	3.5e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PPARA—liver cancer	4.77e-06	3.5e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—HMOX1—liver cancer	4.76e-06	3.5e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—GSTP1—liver cancer	4.73e-06	3.47e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GOT2—liver cancer	4.7e-06	3.46e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—HMOX1—liver cancer	4.66e-06	3.42e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PIK3CD—liver cancer	4.66e-06	3.42e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PIK3CD—liver cancer	4.66e-06	3.42e-05	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	4.65e-06	3.41e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CYCS—liver cancer	4.64e-06	3.41e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—CYCS—liver cancer	4.61e-06	3.39e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—ALB—liver cancer	4.6e-06	3.38e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—ALB—liver cancer	4.6e-06	3.38e-05	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—AKT1—liver cancer	4.56e-06	3.35e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—GGT1—liver cancer	4.55e-06	3.34e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—GOT1—liver cancer	4.55e-06	3.34e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—GGT1—liver cancer	4.52e-06	3.32e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—GOT1—liver cancer	4.52e-06	3.32e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.48e-06	3.29e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—GSTP1—liver cancer	4.46e-06	3.27e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PSMA4—liver cancer	4.45e-06	3.27e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PSMD10—liver cancer	4.45e-06	3.27e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—GSTM1—liver cancer	4.44e-06	3.26e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CYP2E1—liver cancer	4.42e-06	3.25e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.42e-06	3.25e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PSMD10—liver cancer	4.41e-06	3.24e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PSMA4—liver cancer	4.41e-06	3.24e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—HMOX1—liver cancer	4.4e-06	3.23e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GSTA4—liver cancer	4.39e-06	3.22e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.36e-06	3.2e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—GSTM1—liver cancer	4.35e-06	3.19e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CD—liver cancer	4.34e-06	3.19e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GOT2—liver cancer	4.33e-06	3.18e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GOT2—liver cancer	4.29e-06	3.15e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—ALB—liver cancer	4.29e-06	3.15e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.28e-06	3.15e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GSTA2—liver cancer	4.28e-06	3.14e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—HPGDS—liver cancer	4.23e-06	3.1e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CYP1A1—liver cancer	4.21e-06	3.09e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.2e-06	3.09e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CYCS—liver cancer	4.14e-06	3.04e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GSTA1—liver cancer	4.13e-06	3.03e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CYP1A1—liver cancer	4.12e-06	3.02e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—GSTM1—liver cancer	4.1e-06	3.01e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—VEGFA—liver cancer	4.09e-06	3e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—GSTP1—liver cancer	4.09e-06	3e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CG—liver cancer	4.08e-06	3e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—NAT2—liver cancer	4.08e-06	3e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CYP2E1—liver cancer	4.07e-06	2.99e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—GSTP1—liver cancer	4.06e-06	2.98e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GGT1—liver cancer	4.06e-06	2.98e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GOT1—liver cancer	4.06e-06	2.98e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PIK3CB—liver cancer	4.06e-06	2.98e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PIK3CB—liver cancer	4.06e-06	2.98e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CYP2E1—liver cancer	4.03e-06	2.96e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—HMOX1—liver cancer	4.03e-06	2.96e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—HMOX1—liver cancer	4.01e-06	2.94e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PPARG—liver cancer	3.94e-06	2.89e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—MTHFR—liver cancer	3.92e-06	2.88e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—ALDOB—liver cancer	3.91e-06	2.87e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.91e-06	2.87e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PPARA—liver cancer	3.85e-06	2.82e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—MTHFR—liver cancer	3.84e-06	2.82e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.83e-06	2.81e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CYCS—liver cancer	3.81e-06	2.8e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CB—liver cancer	3.78e-06	2.78e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.78e-06	2.78e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CYCS—liver cancer	3.77e-06	2.77e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PSMA4—liver cancer	3.77e-06	2.77e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PSMD10—liver cancer	3.77e-06	2.77e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PPARA—liver cancer	3.77e-06	2.77e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—GSTM1—liver cancer	3.76e-06	2.76e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—TGFB1—liver cancer	3.75e-06	2.76e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GGT1—liver cancer	3.74e-06	2.74e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GOT1—liver cancer	3.74e-06	2.74e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—GSTM1—liver cancer	3.73e-06	2.74e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CRABP1—liver cancer	3.73e-06	2.74e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GGT1—liver cancer	3.7e-06	2.72e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GOT1—liver cancer	3.7e-06	2.72e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GOT2—liver cancer	3.67e-06	2.69e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GSTP1—liver cancer	3.65e-06	2.68e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—MTHFR—liver cancer	3.62e-06	2.66e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—HMOX1—liver cancer	3.6e-06	2.64e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CD—liver cancer	3.59e-06	2.64e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CYP1A1—liver cancer	3.56e-06	2.61e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PPARA—liver cancer	3.55e-06	2.61e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—ALB—liver cancer	3.54e-06	2.6e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—CYP1A1—liver cancer	3.54e-06	2.6e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—KRAS—liver cancer	3.48e-06	2.55e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CYP2E1—liver cancer	3.45e-06	2.53e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GSTP1—liver cancer	3.36e-06	2.46e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GSTM1—liver cancer	3.35e-06	2.46e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.34e-06	2.45e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GSTP1—liver cancer	3.33e-06	2.44e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—MTHFR—liver cancer	3.32e-06	2.44e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—HMOX1—liver cancer	3.31e-06	2.43e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—MTHFR—liver cancer	3.3e-06	2.42e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CG—liver cancer	3.29e-06	2.42e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—HMOX1—liver cancer	3.28e-06	2.41e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—HPGDS—liver cancer	3.26e-06	2.4e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PPARA—liver cancer	3.26e-06	2.39e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PPARA—liver cancer	3.24e-06	2.38e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CG—liver cancer	3.23e-06	2.37e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CYCS—liver cancer	3.22e-06	2.37e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—PIK3CA—liver cancer	3.19e-06	2.35e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.19e-06	2.34e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PPARG—liver cancer	3.18e-06	2.33e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CYP1A1—liver cancer	3.18e-06	2.33e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GOT1—liver cancer	3.16e-06	2.32e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GGT1—liver cancer	3.16e-06	2.32e-05	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PIK3CA—liver cancer	3.13e-06	2.3e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CB—liver cancer	3.13e-06	2.3e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PPARG—liver cancer	3.11e-06	2.29e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—TP53—liver cancer	3.09e-06	2.27e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GSTM1—liver cancer	3.08e-06	2.26e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GSTM1—liver cancer	3.06e-06	2.24e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CG—liver cancer	3.04e-06	2.23e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—MTHFR—liver cancer	2.96e-06	2.18e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—HRAS—liver cancer	2.96e-06	2.17e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PPARG—liver cancer	2.94e-06	2.16e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.93e-06	2.15e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CYP1A1—liver cancer	2.92e-06	2.15e-05	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.91e-06	2.14e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PSMA4—liver cancer	2.91e-06	2.14e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PSMD10—liver cancer	2.91e-06	2.14e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PPARA—liver cancer	2.91e-06	2.13e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CYP1A1—liver cancer	2.9e-06	2.13e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CD—liver cancer	2.9e-06	2.13e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—ALB—liver cancer	2.86e-06	2.1e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GSTP1—liver cancer	2.84e-06	2.09e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CD—liver cancer	2.84e-06	2.08e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GOT2—liver cancer	2.83e-06	2.08e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—HMOX1—liver cancer	2.8e-06	2.06e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—ALB—liver cancer	2.8e-06	2.06e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CG—liver cancer	2.79e-06	2.05e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CG—liver cancer	2.77e-06	2.04e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—MTHFR—liver cancer	2.73e-06	2e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—MTHFR—liver cancer	2.7e-06	1.98e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PPARG—liver cancer	2.69e-06	1.98e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PPARG—liver cancer	2.68e-06	1.97e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CD—liver cancer	2.67e-06	1.96e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PPARA—liver cancer	2.67e-06	1.96e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CYP2E1—liver cancer	2.66e-06	1.95e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PPARA—liver cancer	2.65e-06	1.95e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—ALB—liver cancer	2.64e-06	1.94e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GSTM1—liver cancer	2.61e-06	1.92e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.61e-06	1.92e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—AKT1—liver cancer	2.61e-06	1.92e-05	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—AKT1—liver cancer	2.56e-06	1.88e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CB—liver cancer	2.52e-06	1.85e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CG—liver cancer	2.49e-06	1.83e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CYCS—liver cancer	2.49e-06	1.83e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CYP1A1—liver cancer	2.48e-06	1.82e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PIK3CA—liver cancer	2.47e-06	1.82e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PIK3CA—liver cancer	2.47e-06	1.82e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CB—liver cancer	2.47e-06	1.82e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CD—liver cancer	2.45e-06	1.8e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GGT1—liver cancer	2.44e-06	1.79e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GOT1—liver cancer	2.44e-06	1.79e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CD—liver cancer	2.44e-06	1.79e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—ALB—liver cancer	2.42e-06	1.78e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PPARG—liver cancer	2.4e-06	1.76e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.38e-06	1.75e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CB—liver cancer	2.33e-06	1.71e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—MTHFR—liver cancer	2.31e-06	1.7e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CA—liver cancer	2.31e-06	1.69e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CG—liver cancer	2.29e-06	1.68e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CG—liver cancer	2.27e-06	1.67e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PPARA—liver cancer	2.26e-06	1.66e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PPARG—liver cancer	2.21e-06	1.62e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GSTP1—liver cancer	2.19e-06	1.61e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PPARG—liver cancer	2.19e-06	1.61e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CD—liver cancer	2.19e-06	1.61e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—HMOX1—liver cancer	2.16e-06	1.59e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—ALB—liver cancer	2.16e-06	1.59e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CB—liver cancer	2.14e-06	1.57e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CB—liver cancer	2.12e-06	1.56e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.03e-06	1.49e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—AKT1—liver cancer	2.02e-06	1.48e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—AKT1—liver cancer	2.02e-06	1.48e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GSTM1—liver cancer	2.02e-06	1.48e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CD—liver cancer	2.01e-06	1.48e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CD—liver cancer	2e-06	1.47e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—ALB—liver cancer	1.99e-06	1.46e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—ALB—liver cancer	1.97e-06	1.45e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CG—liver cancer	1.94e-06	1.42e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CYP1A1—liver cancer	1.91e-06	1.4e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CB—liver cancer	1.91e-06	1.4e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CA—liver cancer	1.91e-06	1.4e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—AKT1—liver cancer	1.88e-06	1.38e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PPARG—liver cancer	1.87e-06	1.37e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—MTHFR—liver cancer	1.78e-06	1.31e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CB—liver cancer	1.75e-06	1.29e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PPARA—liver cancer	1.75e-06	1.28e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CB—liver cancer	1.74e-06	1.28e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CD—liver cancer	1.71e-06	1.25e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—ALB—liver cancer	1.68e-06	1.24e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—AKT1—liver cancer	1.56e-06	1.14e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CA—liver cancer	1.54e-06	1.13e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CA—liver cancer	1.51e-06	1.11e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CG—liver cancer	1.5e-06	1.1e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CB—liver cancer	1.49e-06	1.09e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PPARG—liver cancer	1.44e-06	1.06e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CA—liver cancer	1.42e-06	1.04e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CD—liver cancer	1.32e-06	9.66e-06	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CA—liver cancer	1.3e-06	9.57e-06	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—ALB—liver cancer	1.3e-06	9.54e-06	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CA—liver cancer	1.3e-06	9.51e-06	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—AKT1—liver cancer	1.26e-06	9.23e-06	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—AKT1—liver cancer	1.23e-06	9.04e-06	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CA—liver cancer	1.16e-06	8.54e-06	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—AKT1—liver cancer	1.16e-06	8.52e-06	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CB—liver cancer	1.15e-06	8.42e-06	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CA—liver cancer	1.07e-06	7.85e-06	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—AKT1—liver cancer	1.06e-06	7.81e-06	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CA—liver cancer	1.06e-06	7.79e-06	CbGpPWpGaD
Propofol—ALB—Metabolism—AKT1—liver cancer	1.06e-06	7.77e-06	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—AKT1—liver cancer	9.5e-07	6.98e-06	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CA—liver cancer	9.06e-07	6.65e-06	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—AKT1—liver cancer	8.74e-07	6.42e-06	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—AKT1—liver cancer	8.66e-07	6.36e-06	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—AKT1—liver cancer	7.4e-07	5.44e-06	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CA—liver cancer	6.99e-07	5.13e-06	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—AKT1—liver cancer	5.71e-07	4.19e-06	CbGpPWpGaD
